for the Alzheimer’s Disease Neuroimaging Initiative (ADNI)

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Harnessing peripheral DNA methylation differences in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease”.

Harnessing peripheral DNA methylation differences in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease

Clinical Epigenetics(2020)10.1186/s13148-020-00864-y

N/A

0DataRank · unranked

105 citations

J. Wade Davis, Kenneth B. Idler, Jeffrey F. Waring, Elizabeth Asque, Bridget Riley‐Gillis +14 more

Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals

Alzheimer s Research & Therapy(2020)10.1186/s13195-020-00696-1

N/A

0DataRank · unranked

65 citations

Julien Dumurgier, Xavier Ayrignac, Cécilia Marelli, Daniel Alcolea, Juan Fortea +13 more

Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals

medRxiv(2020)10.1101/2020.06.02.20119578

N/A

0DataRank · unranked

1 citations

Julien Dumurgier, Xavier Ayrignac, Cécilia Marelli, Daniel Alcolea, Juan Fortea +13 more

Coping with brain amyloid: genetic heterogeneity and cognitive resilience to Alzheimer’s pathophysiology

Acta Neuropathologica Communications(2021)10.1186/s40478-021-01154-1

N/A

0DataRank · unranked

41 citations

Vijay K. Ramanan, Timothy G. Lesnick, Scott A. Przybelski, Michael G. Heckman, David S. Knopman +9 more

Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts

European Journal of Nuclear Medicine and Molecular Imaging(2021)10.1007/s00259-020-05152-8

N/A

0DataRank · unranked

24 citations

Leonardo Iaccarino, David N. Soleimani‐Meigooni, Suzanne L. Baker, Lauren Edwards, Udo Eichenlaub +16 more

A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer’s Disease Spectrum

Journal of Alzheimer s Disease(2021)10.3233/jad-210573

N/A

0DataRank · unranked

19 citations

Mirella Russo, Raffaella Franciotti, Davide Nardini, Giorgio Maria Mandolini, Alberto Granzotto +8 more

Cortical microstructural associations with CSF amyloid and pTau

Molecular Psychiatry(2023)10.1038/s41380-023-02321-7

N/A

0DataRank · unranked

25 citations

Julio E. Villalón‐Reina, Lauren E. Salminen, Elizabeth Haddad, Hong Zheng, Sophia I. Thomopoulos +6 more

CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET

Nature Communications(2024)10.1038/s41467-024-52298-2

N/A

0DataRank · unranked

12 citations

Shannon L. Risacher, Liana G. Apostolova, Paula J. Bice, Jared R. Brosch, Rachael Deardorff +57 more

Patient stratification by genetic risk in Alzheimer’s disease is only effective in the presence of phenotypic heterogeneity

PLoS ONE(2025)10.1371/journal.pone.0310977

N/A

0DataRank · unranked

4 citations

Muhammad Ali, Chloe Robins, Praveen Surendran, Padhraig Gormley, for the Alzheimer’s Disease Neuroimaging Initiative (ADNI) +3 more

Independent validation of the PrecivityAD2™ blood test to identify presence or absence of brain amyloid pathology in individuals with cognitive impairment

npj Dementia(2025)10.1038/s44400-025-00026-y

N/A

0DataRank · unranked

1 citations

Tim West, Kris Kirmess, I. Fogelman, Sutapa Ray, Philip B. Verghese +4 more